Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Wilms’ tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p

Fig. 4

Network analysis of WT1 co-expressed genes indicates its participation in NSCLC progression. (A) Protein interaction network of WT1 co-expressed genes screened by cBioportal and plotted by STRING. (B) GO enrichment (BP: biological process, MF: molecular function, CC: cellular component) and KEGG pathway analyses of WT1 co-expressed genes. –Log10 transformed false discovery rates (FDR) were plotted for each enriched functional category. (C) Western blot examination of WT1, MYC and MMP2 after WT1 siRNA transfection in A549 and H1299 cells

Back to article page